CHEST Immersion Interstitial Lung Disease-Epidemiology, Diagnosis and Prognosis

Video Transcription

Video Summary

Dr. Stephen Nathan, the Medical Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital, discusses pulmonary hypertension in association with interstitial lung disease (ILD). He begins by explaining the prevalence of pulmonary hypertension in various forms of ILD and the impact on prognosis. The prevalence ranges from 1% in chronic obstructive pulmonary disease (COPD) to as high as 50% in idiopathic pulmonary fibrosis (IPF). Dr. Nathan also highlights the importance of early diagnosis and the use of different parameters such as pulmonary function tests, six-minute walk distance, echocardiography, and CT scans to assess the risk of pulmonary hypertension. He emphasizes the need for a comprehensive approach to evaluate patients and discusses the limitations of current diagnostic tools. Dr. Nathan concludes by acknowledging the challenges of defining and classifying pulmonary hypertension and ILD, and highlights the need for ongoing research in this area.

Keywords

pulmonary hypertension

interstitial lung disease

prevalence

prognosis

early diagnosis

diagnostic tools

PH